Tercica's P2P Acquisition

Tercica raised a round of funding on October 17, 2008. Investors include Ipsen.

Tercica is a biopharmaceutical company committed to improving endocrine health by partnering with the endocrine community to develop and commercialize new therapeutics for pediatric and adult growth d…

Articles about Tercica's P2P Acquisition: